GE Healthcare, LLC recalls Proteus XR/a The Proteus XR/a radiographic system offers the flexibility to choose a configuration based upon your spec…
- Recall date
- March 29, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1752-2019
- FDA classification
- Class II
- Brand / firm
- GE Healthcare, LLC
- Sold / distributed
- Worldwide Distribution: US (nationwide) to states of: AL, CA, CT, FL, GA, HI, IL, LA, MD, MI, MN, MO, NH, NY, OK, PA, TN, and VA; and countries of: Algeria, Argentina, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Canada, China, Costa Rica, Cote D'Ivoire, Cyprus, Czech Republic, Egypt , France,…
Why it was recalled
There has been a reported incident of a Distar CRT monitor that has fallen off the monitor wall mount related to product aging.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Proteus XR/a The Proteus XR/a radiographic system offers the flexibility to choose a configuration based upon your specific requirements. The system provides exceptional image quality, high frequency X-ray generation, easy patient positioning, intuitive operator control and minimal system maintenance.
Get recall alerts
Free email alert whenever GE Healthcare, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GE Healthcare, LLC